Tobramycin News
Tobramycin currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Tobramycin with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Vantobra is indicated for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients aged 6 years and older with cystic fibrosis (CF). Consideration should be given...
- Evidence level: L5
- Predicted indications (20):
- punctate epithelial keratoconjunctivitis (100.0%)
- exposure keratitis (99.9%)
- non-human animal disease (99.8%)
- otitis externa (99.8%)
- postinfectious vasculitis (99.8%)
- post-bacterial disorder (99.8%)
- post-infectious syndrome (99.8%)
- infective urethral stricture (99.8%)
- Chagas cardiomyopathy (99.8%)
- infection-related hemolytic uremic syndrome (99.8%)
- neurotrophic keratopathy (99.8%)
- acute contagious conjunctivitis (99.7%)
- superior limbic keratoconjunctivitis (99.5%)
- conjunctivitis (99.4%)
- epidemic keratoconjunctivitis (99.4%)
- eye infectious disease (99.4%)
- globe disease (99.3%)
- papillary conjunctivitis (99.3%)
- bronchitis (99.1%)
- blepharoconjunctivitis (99.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.